Gene expression changes in residual advanced cervical cancer after radiotherapy: Indicators of poor prognosis and radioresistance?

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1276-1287

  Fu, Zhi Chao ^a   Wang, Feng Mei ^a   Cai, Jian Ming ^b  

^a Institute of Hapatic Disease   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemokine CXCL12; Prognosis; Radioligand assay; Transcriptome

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL ADHESION; CELL CYCLE REGULATION; CELL DEATH; CELL GROWTH; DNA MICROARRAY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; RADIATION DOSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR BIOPSY; UPREGULATION; UTERINE CERVIX CANCER; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOKINE CXCL12; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84928967119     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893689     Document Type: Article

References (22)

1. Yang L, Parkin DM, Ferlay J et al: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005; 14: 243–50
2. Peltenburg LT: Radiosensitivity of tumor cells. Oncogenes and apoptosis. Q J Nucl Med, 2000; 44: 355–64
3. Awasthi S, Singhal SS, Yadav S et al: RLIP76 is a major determinant of radiation sensitivity. Cancer Res, 2005; 65: 6022–28
4. Muralidhar GG, Barbolina MV: Chemokine receptors in epithelial ovarian cancer. Int J Mol Sci, 2013; 15: 361–76
5. Dehghani M, Kianpour S, Zangeneh A et al: CXCL12 Modulates prostate cancer cell adhesion by altering the levels or activities of b1-containing integrins. Int J Cell Biol, 2014; 2014: 981750
6. Bajetto A, Barbieri F, Pattarozzi A et al: CXCR4 and SDF1expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro Oncol, 2007; 9: 3–11
7. Fridrichova I, Smolkova B, Kajabova V et al: CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers. Transl Res, 2015; pii: S1931-5244(14)00470-8
8. Wolff HA, Rolke D, Rave-Fränk M et al: Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines. Radiat Environ Biophys, 2011; 50: 145–54
9. Wang SC, Yu CF, Hong JH, Tsai CS, Chiang CS: Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis. PLoS One, 2013; 8(8): e69182
10. Jaafar F, Righi E, Lindstrom V et al: Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer. Am J Pathol, 2009; 175(4): 1525–35
11. Li P, Zhou C, Xu L, Xiao H: Hypoxia enhances stemness of cancer stem cells in glioblastoma: an in vitro study. Int J Med Sci, 2013; 10(4): 399–407
12. Schrevel M, Karim R, ter Haar NT et al: CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. Br J Cancer, 2012; 106(9): 1520–25
13. Savitsky K, Bar-Shira A, Gilad S et al: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 1995; 268(5218): 1749–53
14. Golding SE, Rosenberg E, Valerie N et al: Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther, 2009; 8: 2894–902
15. Batey MA, Zhao Y, Kyle S et al: Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer. Mol Cancer Ther, 2013; 12: 959–67
16. Asuthkar S, Velpula KK, Nalla AK et al: Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells. Oncogene, 2014; 33(15): 1922–33
17. Maddirela DR, Kesanakurti D, Gujrati M et al: MMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting avb3-mediated SDF-1/CXCR4 signaling. Int J Oncol, 2013; 42(4): 1279–88
18. Qian LW, Mizumoto K, Urashima T et al: Radiationinduced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res, 2002; 8(4): 1223–27
19. Lee WH, Warrington JP, Sonntag WE et al: Irradiation alters MMP-2/TIMP- 2 system and collagen type IV degradation in brain. Int J Radiat Oncol Biol Phys, 2012; 82(5): 1559–66
20. Speake WJ, Dean RA, Kumar A et al: Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion. Eur J Surg Oncol, 2005; 3(8): 869–74
21. Park MH, Ahn BH, Hong YK et al: Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis, 2009; 30(2): 356–65
22. Chetty C, Bhoopathi P, Rao JS et al: Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer, 2009; 124(10): 2468–77